Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Khiron Life Sciences Corp. (V:KHRN)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for KHRN within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jan 19, 2023 06:28 ET
Khiron begins dispensation of insurance-covered prescriptions in Colombia
Following the Government of Colombia's decision on insurance coverage for medical cannabis, Khiron has begun dispensing medical cannabis to its patient base under the new mandate.TORONTO, Jan. 19, 2023 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), announces that it has begun dispensing medical cannabis to patients in its wholly owned ZereniaTM clinic, under the insurance coverage system approved by the Government of Colombia on January 1st, 2023.
Read full article
Jan 19, 2023 06:28 ET
Khiron begins dispensation of insurance-covered prescriptions in Colombia
Following the Government of Colombia's decision on insurance coverage for medical cannabis, Khiron has begun dispensing medical cannabis to its patient base under the new mandate.TORONTO, Jan. 19, 2023 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), announces that it has begun dispensing medical cannabis to patients in its wholly owned ZereniaTM clinic, under the insurance coverage system approved by the Government of Colombia on January 1st, 2023.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
2.68
--
--
Price to Sales - TTM
1.63
3.46
4.89
Price to Book - most recent quarter
0.96
1.05
1.79
Price to Cash Flow per share - TTM
--
8.54
9.87
Price to Free Cash Flow per share - TTM
--
9.19
12.79
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jan 15, 2023262,103-101,874
Dec 31, 2022363,977-186,007
Dec 15, 2022549,984352,841
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Khiron Life Sciences Corp. (Khiron) is a vertically integrated international medical cannabis company with core operations in Latin America and Europe. The Company's product lines include medical cannabis products, health services and wellbeing products. The medical cannabis product sells branded medical cannabis products. The health service operates its own network of medium complexity health centers (operating under the ILANS and Zerenia brands) and Zerenia satellite clinics offering a range of health, medical and surgical services in alignment with insurance company partners. Its wellbeing product is focused on delivering the benefits of cannabidiol (CBD) a range of various branded consumer packaged goods, such as its Kuida cosmetics line. The Company provides patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure. The Company sells its products in Colombia, Peru, Germany, United Kingdom and Brazil.

See business summary

 

Twitter

Search (past week) for $KHRN.CA KHRN.V

  • No tweets found